ABBVIE FDA Approval NDA 019304

NDA 019304

ABBVIE

FDA Drug Application

Application #019304

Documents

Letter2000-04-24
Review1998-10-26
Label2000-04-11
Review2010-03-16
Review2001-06-08

Application Sponsors

NDA 019304ABBVIE

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001CAPSULE;ORAL100MG0LIPIDILFENOFIBRATE
002CAPSULE;ORAL67MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1TRICOR (MICRONIZED)FENOFIBRATE
003CAPSULE;ORAL134MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1TRICOR (MICRONIZED)FENOFIBRATE
004CAPSULE;ORAL200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1TRICOR (MICRONIZED)FENOFIBRATE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1993-12-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1999-04-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1999-06-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1999-06-28STANDARD
EFFICACY; EfficacySUPPL5AP2000-04-24UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2002-03-19STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19304
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.